Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine.
Journal Information
Full Title: J Pharm Sci
Abbreviation: J Pharm Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Evidence found in paper:
"The authors wish to thank Bill and Melinda Gates Foundation for providing the financial support for this study. The authors also wish to acknowledge and thank PATH for providing the three bulk NRRV antigens. The authors would also like to thank Dr. Ronald Toth at KU for acquiring the SV-AUC data."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025